Effect of human tears on Acanthamoeba-induced cytopathic effect

Archives of Ophthalmology

Volumn 126, Issue 3, 2008, Pages 348-352

  Cao, Zhiyi ^a   Saravanan, Chandrassegar ^a   Goldstein, Michael H ^a   Wu, Helen K ^a   Pasricha, Gunisha ^b   Sharma, Savitri ^b   Panjwani, Noorjahan ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b L V PRASAD EYE INSTITUTE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A;

ACANTHAMOEBA CASTELLANII; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CORNEA EPITHELIUM; CULTURE MEDIUM; CYTOPATHOGENIC EFFECT; GIEMSA STAIN; IN VITRO STUDY; INCUBATION TIME; LACRIMAL FLUID; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; RABBIT; TARGET CELL DESTRUCTION;

ACANTHAMOEBA CASTELLANII; ADULT; ANIMALS; CELLS, CULTURED; EPITHELIUM, CORNEAL; EYE PROTEINS; HUMANS; IMMUNOGLOBULIN A, SECRETORY; RABBITS; TEARS;

EID: 40849145468     PISSN: 00039950     EISSN: 00039950     Source Type: Journal    
DOI: 10.1001/archophthalmol.2007.74     Document Type: Article

References (14)

1. Awwad ST, Petroll WM, McCulley JP, et al. Updates in Acanthamoeba keratitis. Eye Contact Lens. 2007;33(1):1-8.
2. Hammersmith KM. Diagnosis and management of Acanthamoeba keratitis. Curr Opin Ophthalmol. 2006;17(4):327-331.
3. Seal DV. Acanthamoeba keratitis update: incidence, molecular epidemiology and new drugs for treatment. Eye. 2003;17(8):893-905.
4. Stehr-Green JK, Bailey TM, Visvesvara GS. The epidemiology of Acanthamoeba keratitis in the United States. Am J Ophthalmol. 1989;107(4):331-336.
5. Joslin CE, Tu EY, McMahon TT, et al. Epidemiological characteristics of a Chicagoarea Acanthamoeba keratitis outbreak. Am J Ophthalmol. 2006;142(2):212-217.
6. Thebpatiphat N, Hammersmith KM, Rocha FN, et al. Acanthamoeba keratitis: a parasite on the rise. Cornea. 2007;26(6):701-706.
7. Marciano-Cabral F, Cabral G. Acanthamoeba spp. as agents of disease in humans. Clin Microbiol Rev. 2003;16(2):273-307.
8. Niederkorn JY, Alizadeh H, Leher H, et al. Role of tear anti-acanthamoeba IgA in Acanthamoeba keratitis. Adv Exp Med Biol. 2002;506(pt B):845-850.
9. Cao Z, Jefferson DM, Panjwani N. Role of carbohydrate-mediated adherence in cytopathogenic mechanisms of Acanthamoeba. J Biol Chem. 1998;273(25):15838-15845.
10. Bjerrum KB, Prause JU. Collection and concentration of tear proteins studied by SDS gel electrophoresis: presentation of a new method with special reference to dry eye patients. Graefes Arch Clin Exp Ophthalmol. 1994;232(7):402-405.
11. Ng V, Cho P, Wong F, et al. Variability of tear protein levels in normal young adults: diurnal (daytime) variation. Graefes Arch Clin Exp Ophthalmol. 2001;239(4):257-263.
12. Hurt M, Neelam S, Niederkorn J, et al. Pathogenic Acanthamoeba spp secrete a mannose-induced cytolytic protein that correlates with the ability to cause disease. Infect Immun. 2003;71(11):6243-6255.
13. Kim WT, Kong HH, Ha YR, et al. Comparison of specific activity and cytopathic effects of purified 33 kDa serine proteinase from Acanthamoeba strains with different degree of virulence. Korean J Parasitol. 2006;44(4):321-330.
14. Sathe S, Sakata M, Beaton AR, et al. Identification, origins and the diurnal role of the principal serine protease inhibitors in human tear fluid. Curr Eye Res. 1998;17(4):348-362.